{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:38:46Z","timestamp":1791049126859,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical and Health Science and Technology Innovation project of Chinese Academy of Medical Sciences","award":["2017-I2M-1-016"],"award-info":[{"award-number":["2017-I2M-1-016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04030-9","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T13:44:22Z","timestamp":1755870262000},"page":"701-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical value of ENO2 in serum extracellular vesicles for the diagnosis and prognosis of diffuse large B-cell lymphoma patients"],"prefix":"10.1007","volume":"28","author":[{"given":"Ruiyu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2352-2871","authenticated-orcid":false,"given":"Pingping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"1","key":"4030_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","volume":"50","author":"S Li","year":"2018","unstructured":"Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50(1):74\u201387.","journal-title":"Pathology"},{"issue":"9","key":"4030_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med. 2021;384(9):842\u201358.","journal-title":"N Engl J Med"},{"issue":"12","key":"4030_CR3","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.clml.2017.10.007","volume":"17","author":"F Cabanillas","year":"2017","unstructured":"Cabanillas F, Shah B. Advances in diagnosis and management of diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk. 2017;17(12):783\u201396.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"4030_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.seminhematol.2023.11.006","volume":"60","author":"LK Hilton","year":"2023","unstructured":"Hilton LK, Scott DW, Morin RD. Biological heterogeneity in diffuse large B-cell lymphoma. Semin Hematol. 2023;60(5):267\u201376.","journal-title":"Semin Hematol"},{"issue":"1","key":"4030_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/oncolo\/oyab004","volume":"27","author":"AV Danilov","year":"2022","unstructured":"Danilov AV, Magagnoli M, Matasar MJ. Translating the biology of diffuse large B-cell lymphoma into treatment. Oncologist. 2022;27(1):57\u201366.","journal-title":"Oncologist"},{"key":"4030_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102443","volume":"110","author":"S Poletto","year":"2022","unstructured":"Poletto S, Novo M, Paruzzo L, Frascione PMM, Vitolo U. Treatment strategies for patients with diffuse large B-cell lymphoma. Cancer Treat Rev. 2022;110: 102443.","journal-title":"Cancer Treat Rev"},{"key":"4030_CR7","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Yanez-Mo","year":"2015","unstructured":"Yanez-Mo M, Siljander PR, Andreu Z, Zavec AB, Borras FE, Buzas EI, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.","journal-title":"J Extracell Vesicles"},{"issue":"3","key":"4030_CR8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2741\/4811","volume":"25","author":"AS Carvalho","year":"2020","unstructured":"Carvalho AS, Baeta H, Silva BC, Moraes MCS, Bodo C, Beck HC, et al. Extra-cellular vesicles carry proteome of cancer hallmarks. Front Biosci (Landmark Ed). 2020;25(3):398\u2013436.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"21","key":"4030_CR9","doi-asserted-by":"publisher","first-page":"13327","DOI":"10.3390\/ijms232113327","volume":"23","author":"R Matthiesen","year":"2022","unstructured":"Matthiesen R, Gameiro P, Henriques A, Bodo C, Moraes MCS, Costa-Silva B, et al. Extracellular vesicles in diffuse large B cell lymphoma: characterization and diagnostic potential. Int J Mol Sci. 2022;23(21):13327.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4030_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/bcp.14611","volume":"87","author":"K Ofori","year":"2021","unstructured":"Ofori K, Bhagat G, Rai AJ. Exosomes and extracellular vesicles as liquid biopsy biomarkers in diffuse large B-cell lymphoma: current state of the art and unmet clinical needs. Br J Clin Pharmacol. 2021;87(2):284\u201394.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"4030_CR11","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.3390\/biomedicines12122822","volume":"12","author":"T Punnachet","year":"2024","unstructured":"Punnachet T, Chattipakorn SC, Chattipakorn N, Kumfu S. Critical role of extracellular vesicles in diffuse large B-cell lymphoma; pathogenesis, potential biomarkers, and targeted therapy\u2014a narrative review. Biomedicines. 2024;12(12):2822.","journal-title":"Biomedicines"},{"key":"4030_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-94-017-7215-0_9","volume":"867","author":"MA Isgro","year":"2015","unstructured":"Isgro MA, Bottoni P, Scatena R. Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv Exp Med Biol. 2015;867:125\u201343.","journal-title":"Adv Exp Med Biol"},{"issue":"14","key":"4030_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16142503","volume":"16","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zeng F, Richards GO, Wang N. ENO2, a glycolytic enzyme, contributes to prostate cancer metastasis: a systematic review of literature. Cancers (Basel). 2024;16(14): 2503.","journal-title":"Cancers (Basel)"},{"issue":"15","key":"4030_CR14","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.3390\/cells11152363","volume":"11","author":"C Lv","year":"2022","unstructured":"Lv C, Yu H, Wang K, Chen C, Tang J, Han F, et al. Eno2 promotes colorectal cancer metastasis by interacting with the LncRNA CYTOR and activating YAP1-induced EMT. Cells. 2022;11(15):2363.","journal-title":"Cells"},{"issue":"2","key":"4030_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3892\/or.2022.8470","volume":"49","author":"WJ Chen","year":"2023","unstructured":"Chen WJ, Yang W, Gong M, He Y, Xu D, Chen JX, et al. ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment. Oncol Rep. 2023;49(2):33.","journal-title":"Oncol Rep"},{"issue":"9","key":"4030_CR16","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3109\/10428194.2011.578187","volume":"52","author":"L Wang","year":"2011","unstructured":"Wang L, Liu P, Geng Q, Chen X, Lv Y. Prognostic significance of neuron-specific enolase in patients with diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy. Leuk Lymphoma. 2011;52(9):1697\u2013703.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"4030_CR17","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s12032-011-0049-z","volume":"29","author":"L Wang","year":"2012","unstructured":"Wang L, Liu P, Chen X, Geng Q, Lu Y. Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy. Med Oncol. 2012;29(3):2153\u20138.","journal-title":"Med Oncol"},{"key":"4030_CR18","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.2147\/CMAR.S203010","volume":"11","author":"MY Zhu","year":"2019","unstructured":"Zhu MY, Liu WJ, Wang H, Wang WD, Liu NW, Lu Y. NSE from diffuse large B-cell lymphoma cells regulates macrophage polarization. Cancer Manag Res. 2019;11:4577\u201395.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"4030_CR19","doi-asserted-by":"publisher","first-page":"848","DOI":"10.7150\/ijbs.91154","volume":"20","author":"R Shao","year":"2024","unstructured":"Shao R, Liu C, Xue R, Deng X, Liu L, Song C, et al. Tumor-derived exosomal ENO2 modulates polarization of tumor-associated macrophages through reprogramming glycolysis to promote progression of diffuse large B-cell lymphoma. Int J Biol Sci. 2024;20(3):848\u201363.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"4030_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/ajh.24223","volume":"91","author":"MJ Maurer","year":"2016","unstructured":"Maurer MJ, Jais JP, Ghesquieres H, Witzig TE, Hong F, Haioun C, et al. Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma. Am J Hematol. 2016;91(2):179\u201384.","journal-title":"Am J Hematol"},{"issue":"suppl 5","key":"4030_CR21","doi-asserted-by":"publisher","first-page":"v91","DOI":"10.1093\/annonc\/mdw175","volume":"27","author":"U Vitolo","year":"2016","unstructured":"Vitolo U, Seymour JF, Martelli M, Illerhaus G, Illidge T, Zucca E, et al. Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v91\u2013102.","journal-title":"Ann Oncol"},{"key":"4030_CR22","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.2147\/DMSO.S370017","volume":"15","author":"W Zhou","year":"2022","unstructured":"Zhou W, Li W, He C, Ma R, Gao Q, Wang Y, et al. Influence of hyperglycemia on the prognosis of patients with diffuse large B-Cell lymphoma. Diabetes Metab Syndr Obes. 2022;15:2039\u201349.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"4030_CR23","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1007\/s00277-024-05880-z","volume":"103","author":"Y Shi","year":"2024","unstructured":"Shi Y, Xu Y, Shen H, Jin J, Tong H, Xie W. Advances in biology, diagnosis and treatment of DLBCL. Ann Hematol. 2024;103(9):3315\u201334.","journal-title":"Ann Hematol"},{"issue":"7","key":"4030_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0307253","volume":"19","author":"P Yimpak","year":"2024","unstructured":"Yimpak P, Bumroongkit K, Tantiworawit A, Rattanathammethee T, Aungsuchawan S, Daroontum T. Immunohistochemistry-based investigation of MYC, BCL2, and Ki-67 protein expression and their clinical impact in diffuse large B-cell lymphoma in upper Northern Thailand. PLoS ONE. 2024;19(7): e0307253.","journal-title":"PLoS ONE"},{"key":"4030_CR25","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3389\/fphar.2018.01497","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Wang H, Ren C, Yu H, Fang W, Zhang N, et al. Correlation between C-MYC, BCL-2, and BCL-6 protein expression and gene translocation as biomarkers in diagnosis and prognosis of diffuse large B-cell lymphoma. Front Pharmacol. 2018;9:1497.","journal-title":"Front Pharmacol"},{"issue":"Suppl 5","key":"4030_CR26","doi-asserted-by":"publisher","first-page":"v116","DOI":"10.1093\/annonc\/mdv304","volume":"26","author":"H Tilly","year":"2015","unstructured":"Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v116-25.","journal-title":"Ann Oncol."},{"issue":"4","key":"4030_CR27","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.7150\/ijbs.67892","volume":"18","author":"XJ Liang","year":"2022","unstructured":"Liang XJ, Song XY, Wu JL, Liu D, Lin BY, Zhou HS, et al. Advances in multi-omics study of prognostic biomarkers of diffuse large B-cell lymphoma. Int J Biol Sci. 2022;18(4):1313\u201327.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"4030_CR28","doi-asserted-by":"publisher","first-page":"C29","DOI":"10.1152\/ajpcell.00280.2019","volume":"318","author":"F Urabe","year":"2020","unstructured":"Urabe F, Kosaka N, Ito K, Kimura T, Egawa S, Ochiya T. Extracellular vesicles as biomarkers and therapeutic targets for cancer. Am J Physiol Cell Physiol. 2020;318(1):C29\u201339.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"23","key":"4030_CR29","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/blood.2019002729","volume":"135","author":"AS Ruppert","year":"2020","unstructured":"Ruppert AS, Dixon JG, Salles G, Wall A, Cunningham D, Poeschel V, et al. International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI. Blood. 2020;135(23):2041\u20138.","journal-title":"Blood"},{"issue":"22","key":"4030_CR30","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.3390\/cancers14225552","volume":"14","author":"K Kluckova","year":"2022","unstructured":"Kluckova K, D\u2019Avola A, Riches JC. Advances in understanding of metabolism of B-cell lymphoma: implications for therapy. Cancers (Basel). 2022;14(22):5552.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4030_CR31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12957-020-01894-9","volume":"18","author":"Z Tian","year":"2020","unstructured":"Tian Z, Liang C, Zhang Z, Wen H, Feng H, Ma Q, et al. Prognostic value of neuron-specific enolase for small cell lung cancer: a systematic review and meta-analysis. World J Surg Oncol. 2020;18(1):116.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"4030_CR32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s12885-024-12332-4","volume":"24","author":"J Cai","year":"2024","unstructured":"Cai J, Yang Y, Zhang L, Fang Y, Zhang Y, Tan M, et al. Investigation of ENO2 as a promising novel marker for the progression of colorectal cancer with microsatellite instability-high. BMC Cancer. 2024;24(1):573.","journal-title":"BMC Cancer"},{"issue":"8","key":"4030_CR33","doi-asserted-by":"publisher","first-page":"BSR20210866","DOI":"10.1042\/BSR20210866","volume":"41","author":"P Yan","year":"2021","unstructured":"Yan P, Han Y, Tong A, Liu J, Wang X, Liu C. Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer. Biosci Rep. 2021;41(8):BSR20210866.","journal-title":"Biosci Rep"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04030-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04030-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04030-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:47:12Z","timestamp":1769694432000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04030-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["4030"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04030-9","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of Critical Care Medicine Diagnosis and Treatment Center of Hematology Hospital and complied with\n                      the Declaration of Helsinki\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}